Vertex Pharmaceuticals, Inc. (VRTX)
547.74
-0.31
(-0.06%)
USD |
NASDAQ |
Aug 24, 16:00
548.20
+0.46
(+0.08%)
After-Hours: 20:00
Vertex Pharmaceuticals Total Assets (Quarterly) : 27.42B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 27.42B |
| March 31, 2026 | 26.48B |
| December 31, 2025 | 26.14B |
| September 30, 2025 | 24.86B |
| June 30, 2025 | 24.04B |
| March 31, 2025 | 22.88B |
| December 31, 2024 | 23.09B |
| September 30, 2024 | 22.24B |
| June 30, 2024 | 20.13B |
| March 31, 2024 | 23.92B |
| December 31, 2023 | 23.09B |
| September 30, 2023 | 21.73B |
| June 30, 2023 | 20.35B |
| March 31, 2023 | 18.97B |
| December 31, 2022 | 18.15B |
| September 30, 2022 | 16.71B |
| June 30, 2022 | 15.58B |
| March 31, 2022 | 14.26B |
| December 31, 2021 | 13.43B |
| September 30, 2021 | 12.62B |
| June 30, 2021 | 12.22B |
| March 31, 2021 | 12.12B |
| December 31, 2020 | 11.75B |
| September 30, 2020 | 11.30B |
| June 30, 2020 | 10.22B |
| Date | Value |
|---|---|
| March 31, 2020 | 8.893B |
| December 31, 2019 | 8.318B |
| September 30, 2019 | 7.515B |
| June 30, 2019 | 7.033B |
| March 31, 2019 | 6.543B |
| December 31, 2018 | 6.246B |
| September 30, 2018 | 4.621B |
| June 30, 2018 | 4.335B |
| March 31, 2018 | 3.953B |
| December 31, 2017 | 3.546B |
| September 30, 2017 | 3.198B |
| June 30, 2017 | 3.286B |
| March 31, 2017 | 2.947B |
| December 31, 2016 | 2.897B |
| September 30, 2016 | 2.610B |
| June 30, 2016 | 2.549B |
| March 31, 2016 | 2.488B |
| December 31, 2015 | 2.499B |
| September 30, 2015 | 2.434B |
| June 30, 2015 | 2.374B |
| March 31, 2015 | 2.166B |
| December 31, 2014 | 2.335B |
| September 30, 2014 | 2.406B |
| June 30, 2014 | 2.118B |
| March 31, 2014 | 2.197B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 49.36B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Regeneron Pharmaceuticals, Inc. | 41.73B |
| Sionna Therapeutics, Inc. | 283.25M |
| Biogen, Inc. | 32.09B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.175B |
| Shareholders Equity (Quarterly) | 20.25B |
| Debt to Equity Ratio | 0.0977 |
| Current Ratio | 3.185 |
| Net Debt Paydown Yield | -0.05% |